.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Serving leading biopharmaceutical companies globally:

Moodys
UBS
Novartis
US Department of Justice
Julphar
Harvard Business School
Deloitte
Farmers Insurance
QuintilesIMS
Daiichi Sankyo

Which drugs have supplementary protection certificates in the most countries?

This chart shows the drugs with the most supplementary protection certificates (SPCs).

SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to obtain regulatory approval for drugs. SPCs come into force only after the corresponding general patent expires, and normally have a maximum lifetime of 5 years.

The total combined duration of market exclusivity of a general patent and SPC cannot normally exceed 15 years, but a six-month extention may be obtained by responding to a request for pediatric trials.

The pharmaceutical drugs with SPCs in the most countries are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot